Sign Up to like & get
recommendations!
1
Published in 2023 at "Neuro-Oncology Practice"
DOI: 10.1093/nop/npad022
Abstract: Recurrent gliomas are therapeutically challenging diseases with few treatment options available. One area of potential therapeutic vulnerability is the presence of targetable oncogenic fusion proteins. To better understand the clinical benefit of routinely testing for…
read more here.
Keywords:
fusion;
transcript panel;
adult glioma;
glioma patients ... See more keywords